IMMUNOMODULATORY PROPERTIES OF THE METAL CHELATORS DESFERRIOXAMINE AND DIETHYLENETRIAMINE PENTA-ACETIC ACID IN VITRO1
- 15 November 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 62 (9) , 1371-1374
- https://doi.org/10.1097/00007890-199611150-00037
Abstract
In this study, we investigated the effects of the intracellular metal chelator desferrioxamine (DFO) and the extracellular metal chelator diethylenetriamine penta-acetic acid (DTPA), which were previously shown to have strong anticytomegalovirus potencies, on their ability to elicit immunomodulatory effects in vitro[fcn,3]. The results showed that nontoxic and in vivo attainable concentrations of both DFO and DTPA inhibited mitogen- and allogen-induced proliferation of peripheral blood lymphocytes. The immunomodulatory effects of DFO/DTPA seem to be due to the impaired expression of interleukin-2 receptor and the reduced secretion of interleukin-2. However, metal chelators were more effective than cyclosporine or tacrolimus (FK506) in our in vitro experiments. Moreover, cytotoxicity mediated by lymphokine-activated killer cells and natural killer cells and the expression of HLA and adhesion molecules on cytokine-stimulated endothelial cells were differentially impaired by DFO/DTPA. These results warrant further study of the immunological effects of metal chelators in vivo.Keywords
This publication has 7 references indexed in Scilit:
- In vitro inhibition of human cytomegalovirus replication by calcium trinatrium diethylenetriaminepentaacetic acidAntiviral Research, 1996
- IMPACT OF OXIDATIVE STRESS ON HUMAN CYTOMEGALOVIRUS REPLICATION AND ON CYTOKINE-MEDIATED STIMULATION OF ENDOTHELIAL CELLS1Transplantation, 1996
- Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cellsTransplant Immunology, 1995
- In vitro inhibition of human cytomegalovirus replication by desferrioxamineAntiviral Research, 1994
- Iron-Chelating Agents in Non-Iron Overload ConditionsAnnals of Internal Medicine, 1994
- CMV INFECTION, CLASS II ANTIGEN EXPRESSION, AND HUMAN KIDNEY ALLOGRAFT REJECTIONTransplantation, 1986
- Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron‐Loaded SubjectsBritish Journal of Haematology, 1979